MINNEAPOLIS, Feb. 1, 2016 /PRNewswire/ -- Verde Technologies announced its Deterra Drug Deactivation System will be featured as part of an innovative program to safely dispose of opioid drugs during the Community Anti-Drug Coalitions of America's (CADCA) 26th Annual National Leadership Forum from February 1 through 4 in National Harbor, Maryland. The Deterra™ Drug Deactivation System is the only scientifically proven technology to safely deactivate and dispose of leftover prescription medications. Deterra places the power to reduce opioid drug abuse and misuse directly in the hands of parents, grandparents and communities across the United States, by providing a way to safely render unused prescription medications inert, including opioids, antibiotics, transdermal patches and other medications from the home.
Verde launched the Deterra Drug Deactivation System in February 2015 and has experienced tremendous growth, especially in the nonprofit sector. CADCA coalitions have publically shared their excitement and support of the Deterra products they've received for use in their communities, including Manatee and Collier counties in Florida. In addition to the CADCA coalitions, nonprofit organizations across the Unites States, including the National Council on Alcohol and Drug Abuse - St. Louis and ACT Missouri, recognize the impact Deterra can have within communities to reduce available opioid prescription drugs for abuse or misuse.
On Thursday, February 4 at 9 a.m., CADCA leaders will host a training session to share their experiences in distributing Deterra through an innovative program in Florida. CADCA's pilot program includes working with four coalitions to identify best practices, distribute Deterra as a new technology in medicine disposal and deploy a survey to better understand attitudes and motivations surrounding the medicines in our homes. Florida coalitions from Collier, Hillsborough, Manatee and Seminole counties are disseminating more than 40,000 Deterra packages and sparking conversations in their community with a wide array of stakeholders.
CADCA forum attendees who attend the Feb. 4 session will receive Deterra samples.
Additional support from the Office of National Drug Control Policy was received through the inclusion of Drug Deactivation Systems in the 2015 strategy. For the first time, the recently revised strategy supports the deactivation and disposal of unwanted prescriptions in the home, which can safely minimize the potential for diversion or accidental poisoning. The updated strategy is available at www.whitehouse.gov//sites/default/files/ondcp/policy-and-research/2015_national_drug_control_strategy.pdf.
Deterra has a 98.1 percent success rate in deactivating prescription drugs, according to a research study supported by the National Institute on Drug Abuse (NIDA). Designed to be a cost-effective and easy-to-use drug abuse deterrent, Deterra is also environmentally friendly as it renders chemical compounds safe for landfills, providing an excellent alternative or complement to take back programs. The product is made from Omnidegradable® material, which is an environmentally responsible way to deactivate and dispose of drugs.
For more information, attend the Feb. 4 training session, visit booth #307 at the 26th Annual CADCA Leadership Forum, or visit www.DeterraSystem.com.
About Verde Technologies
Minneapolis-based Verde Technologies is committed to developing research-based, scientifically proven solutions to reduce drug abuse and misuse. The Deterra Drug Deactivation System is powered by patented MAT12 Molecular Adsorption Technology, which deactivates prescription drugs using proprietary activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive and ineffective for misuse. For more information, visit www.DeterraSystem.com, follow @DeterraSystem on Twitter or like Deterra System on Facebook.
SOURCE Verde Technologies